Owner-User Industrial Advisory | Life Sciences & Pharma

For pharmaceutical, life sciences, and healthcare operators, facility ownership is

often a strategic operating decision, not simply a real estate investment.

We advise owner-occupants on acquisition, disposition, and long-term facility planning with a deep understanding of regulatory exposure, capital structure, operational

risk, and enterprise governance.

Our owner-user advisory includes:

• Acquisition and disposition of owner-occupied industrial and flex assets
• SBA and owner-user financing strategy support
• Facility, expansion, and consolidation planning
• Lease-versus-own analysis
• Long-term operational and regulatory risk assessment

We evaluate real estate decisions through the lens of business continuity, scalability, and integration with internal legal, QA, and compliance teams as part of our life sciences & pharma industrial real estate services.

See types of industrial & flex facilities we specialize in for life sciences and pharma operators.

• Pharmaceutical manufacturers and distributors.  Explore our pharma manufacturing and pharma distribution facilities advisory.
• Life sciences and medical device companies
• Cold-chain and regulated logistics operators.  See our cold-chain & temperature-controlled real estate advisory.
• Healthcare manufacturing and specialty distribution users

We focus on durability, flexibility, and enterprise alignment, whether acquiring a first

facility or optimizing a long-held asset.

Owner-occupied pharmaceutical and life sciences facilities carry:

• High build-out and compliance costs
• Long operational time horizons
• Regulatory and quality risk
• Limited reuse optionality

We structure transactions to protect downside risk while supporting long-term

growth.

If facility ownership is part of your long-term operating plan, your advisory team should understand both real estate and regulated operations.

Visit our Carolinas industrial real estate Resources page for agency disclosures and site selection tools.

Contact us to discuss your strategy.